• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预防慢性肾脏病患者血管钙化的补充营养素。

Supplementary nutrients for prevention of vascular calcification in patients with chronic kidney disease.

机构信息

Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea.

出版信息

Korean J Intern Med. 2019 May;34(3):459-469. doi: 10.3904/kjim.2019.125. Epub 2019 Apr 30.

DOI:10.3904/kjim.2019.125
PMID:31048656
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6506750/
Abstract

Vascular calcification (VC) and malnutrition associated with cardiovascular disease are common in patients with chronic kidney disease (CKD) treated with dialysis. VC, which reflects vascular aging, and malnutrition are also encountered in the non-CKD elderly population. This similarity of clinical findings suggests that the progression of CKD is related to aging and the existence of a causal relationship between VC and malnutrition. To retard renal progression, a low- or very-low-protein diet is usually recommended for CKD patients. Dietary education may induce malnutrition and deficiency of important nutrients, such as vitamins K and D. Menaquinone-7, a type of vitamin K2, is under investigation for inhibiting VC in elderly patients without CKD, as well as for prevention of VC in patients with CKD. Nutritional vitamin D, such as cholecalciferol, may be considered to decrease the required dose of active vitamin D, which increases the risk of VC due to increased calcium and phosphate loads. Omega-3 fatty acids are important nutrients and their ability to inhibit VC needs to be evaluated in clinical trials. This review focuses on the ability of supplementary nutrients to prevent VC in patients with CKD, in whom dietary restriction is essential.

摘要

血管钙化(VC)和与心血管疾病相关的营养不良在接受透析治疗的慢性肾脏病(CKD)患者中很常见。反映血管老化的 VC 和营养不良也存在于非 CKD 老年人群中。这些临床发现的相似性表明,CKD 的进展与衰老有关,并且 VC 和营养不良之间存在因果关系。为了延缓肾脏进展,通常建议 CKD 患者采用低蛋白或极低蛋白饮食。饮食教育可能会导致营养不良和重要营养素(如维生素 K 和 D)的缺乏。甲萘醌-7 是一种维生素 K2,正在研究用于抑制无 CKD 的老年患者的 VC,以及预防 CKD 患者的 VC。营养性维生素 D,如胆钙化醇,可考虑减少活性维生素 D 的所需剂量,因为活性维生素 D 会增加钙和磷酸盐负荷,从而增加 VC 的风险。ω-3 脂肪酸是重要的营养素,需要在临床试验中评估其抑制 VC 的能力。本综述重点介绍补充营养素预防 CKD 患者 VC 的能力,因为饮食限制在 CKD 患者中至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3987/6506750/1554e7f5be16/kjim-2019-125f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3987/6506750/fe7990a2f8b7/kjim-2019-125f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3987/6506750/42e792eab012/kjim-2019-125f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3987/6506750/600eb3c28f35/kjim-2019-125f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3987/6506750/1554e7f5be16/kjim-2019-125f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3987/6506750/fe7990a2f8b7/kjim-2019-125f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3987/6506750/42e792eab012/kjim-2019-125f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3987/6506750/600eb3c28f35/kjim-2019-125f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3987/6506750/1554e7f5be16/kjim-2019-125f4.jpg

相似文献

1
Supplementary nutrients for prevention of vascular calcification in patients with chronic kidney disease.用于预防慢性肾脏病患者血管钙化的补充营养素。
Korean J Intern Med. 2019 May;34(3):459-469. doi: 10.3904/kjim.2019.125. Epub 2019 Apr 30.
2
Role of Vitamin K in CKD: Is Its Supplementation Advisable in CKD Patients?维生素K在慢性肾脏病中的作用:慢性肾脏病患者是否建议补充维生素K?
Kidney Blood Press Res. 2021;46(5):523-530. doi: 10.1159/000516611. Epub 2021 Jul 9.
3
CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies.慢性肾脏病、动脉钙化、动脉粥样硬化和骨骼健康:相互关系和争议。
Atherosclerosis. 2018 Nov;278:49-59. doi: 10.1016/j.atherosclerosis.2018.08.046. Epub 2018 Aug 30.
4
Vitamin K Supplementation for Prevention of Vascular Calcification in Chronic Kidney Disease Patients: Are We There Yet?维生素 K 补充预防慢性肾脏病患者血管钙化:我们做到了吗?
Nutrients. 2022 Feb 22;14(5):925. doi: 10.3390/nu14050925.
5
The role of vitamin K in vascular calcification of patients with chronic kidney disease.维生素K在慢性肾病患者血管钙化中的作用
Acta Clin Belg. 2016 Dec;71(6):462-467. doi: 10.1080/17843286.2016.1180770. Epub 2016 May 25.
6
[Diagnosis and clinical implications of vascular calcification of chronic kidney disease in Mexico].[墨西哥慢性肾脏病血管钙化的诊断及临床意义]
Rev Med Inst Mex Seguro Soc. 2017;55(Suppl 2):S151-7.
7
Recent Advances in the Management of Vascular Calcification in Patients with End-Stage Renal Disease.终末期肾病患者血管钙化管理的最新进展
Contrib Nephrol. 2019;198:62-72. doi: 10.1159/000496532. Epub 2019 Apr 16.
8
Vascular calcification in chronic kidney disease: a review.慢性肾脏病中的血管钙化:综述
J Bras Nefrol. 2013 Apr-Jun;35(2):147-61. doi: 10.5935/0101-2800.20130024.
9
Vitamin K Supplementation to Improve Vascular Stiffness in CKD: The K4Kidneys Randomized Controlled Trial.维生素 K 补充剂改善 CKD 患者血管僵硬:K4Kidneys 随机对照试验。
J Am Soc Nephrol. 2020 Oct;31(10):2434-2445. doi: 10.1681/ASN.2020020225. Epub 2020 Aug 13.
10
Phospholipase D: A new mediator during high phosphate-induced vascular calcification associated with chronic kidney disease.磷脂酶 D:慢性肾脏病相关高磷诱导血管钙化过程中的一种新的介质。
J Cell Physiol. 2019 Apr;234(4):4825-4839. doi: 10.1002/jcp.27281. Epub 2018 Sep 12.

引用本文的文献

1
Extended-Hours Hemodialysis Without Dietary Restrictions Reduces Risk of Vascular Calcification.无饮食限制的延长时间血液透析可降低血管钙化风险。
J Med Cases. 2025 Aug 22;16(8):300-308. doi: 10.14740/jmc5146. eCollection 2025 Aug.
2
Food to Prevent Vascular Calcification in Chronic Kidney Disease.预防慢性肾脏病血管钙化的食物。
Nutrients. 2024 Feb 23;16(5):617. doi: 10.3390/nu16050617.
3
Role of nutritional vitamin D in chronic kidney disease-mineral and bone disorder: A narrative review.营养性维生素 D 在慢性肾脏病-矿物质和骨异常中的作用:叙述性综述。

本文引用的文献

1
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).KDIGO 2017慢性肾脏病-矿物质和骨异常(CKD-MBD)诊断、评估、预防及治疗临床实践指南更新
Kidney Int Suppl (2011). 2017 Jul;7(1):1-59. doi: 10.1016/j.kisu.2017.04.001. Epub 2017 Jun 21.
2
Very low protein diet plus ketoacid analogs of essential amino acids supplement to retard chronic kidney disease progression.极低蛋白饮食加必需氨基酸酮酸类似物补充剂以延缓慢性肾脏病进展。
Kidney Res Clin Pract. 2018 Dec;37(4):384-392. doi: 10.23876/j.krcp.18.0055. Epub 2018 Dec 31.
3
Medicine (Baltimore). 2023 Apr 7;102(14):e33477. doi: 10.1097/MD.0000000000033477.
4
Omega-3 fatty acid and menaquinone-7 combination are helpful for aortic calcification prevention, reducing osteoclast area of bone and Fox0 expression of muscle in uremic rats.ω-3 脂肪酸与甲萘醌-7 联合应用有助于预防主动脉钙化,减少尿毒症大鼠骨破骨细胞面积和肌肉 Fox0 表达。
Ren Fail. 2022 Dec;44(1):1873-1885. doi: 10.1080/0886022X.2022.2142140.
5
Biological Role of Vitamin K-With Particular Emphasis on Cardiovascular and Renal Aspects.维生素 K 的生物学作用——特别强调心血管和肾脏方面。
Nutrients. 2022 Jan 8;14(2):262. doi: 10.3390/nu14020262.
6
Growing Evidence of a Proven Mechanism Shows Vitamin K2 Can Impact Health Conditions Beyond Bone and Cardiovascular.越来越多的确凿证据表明,维生素K2对健康状况的影响不仅限于骨骼和心血管领域。
Integr Med (Encinitas). 2021 Aug;20(4):34-38.
7
Arteriosclerosis, atherosclerosis, arteriolosclerosis, and Monckeberg medial calcific sclerosis: what is the difference?动脉硬化、动脉粥样硬化、小动脉硬化和蒙克贝格(Monckeberg)中膜钙化性硬化:它们之间有什么区别?
J Vasc Bras. 2021 Jun 25;20:e20200211. doi: 10.1590/1677-5449.200211. eCollection 2021.
8
Nutritional management in patients with chronic kidney disease.慢性肾脏病患者的营养管理。
Korean J Intern Med. 2020 Nov;35(6):1279-1290. doi: 10.3904/kjim.2020.408. Epub 2020 Sep 23.
9
Cardiovascular Calcification in Chronic Kidney Disease-Therapeutic Opportunities.慢性肾脏病中的心血管钙化——治疗机遇。
Toxins (Basel). 2020 Mar 14;12(3):181. doi: 10.3390/toxins12030181.
Impact of Blood or Erythrocyte Membrane Fatty Acids for Disease Risk Prediction: Focusing on Cardiovascular Disease and Chronic Kidney Disease.
血液或红细胞膜脂肪酸对疾病风险预测的影响:关注心血管疾病和慢性肾脏病。
Nutrients. 2018 Oct 7;10(10):1454. doi: 10.3390/nu10101454.
4
Effects of education on low-phosphate diet and phosphate binder intake to control serum phosphate among maintenance hemodialysis patients: A randomized controlled trial.教育对维持性血液透析患者低磷饮食及磷结合剂摄入以控制血清磷的影响:一项随机对照试验。
Kidney Res Clin Pract. 2018 Mar;37(1):69-76. doi: 10.23876/j.krcp.2018.37.1.69. Epub 2018 Mar 31.
5
Current characteristics of dialysis therapy in Korea: 2016 registry data focusing on diabetic patients.韩国透析治疗的当前特征:聚焦糖尿病患者的2016年登记数据。
Kidney Res Clin Pract. 2018 Mar;37(1):20-29. doi: 10.23876/j.krcp.2018.37.1.20. Epub 2018 Mar 31.
6
Patient education for hyperphosphatemia management: Improving outcomes while decreasing costs?高磷血症管理的患者教育:改善治疗效果并降低成本?
Kidney Res Clin Pract. 2018 Mar;37(1):4-7. doi: 10.23876/j.krcp.2018.37.1.4. Epub 2018 Mar 31.
7
Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients.骨化三醇和西那卡塞联合治疗血液透析患者重度继发性甲状旁腺功能亢进时,胆钙化醇可进一步降低甲状旁腺激素水平。
Nutrients. 2018 Feb 10;10(2):196. doi: 10.3390/nu10020196.
8
Changes in geriatric nutritional risk index and risk of major adverse cardiac and cerebrovascular events in incident peritoneal dialysis patients.老年腹膜透析初治患者老年营养风险指数变化与主要心脑血管不良事件风险
Kidney Res Clin Pract. 2017 Dec;36(4):377-386. doi: 10.23876/j.krcp.2017.36.4.377. Epub 2017 Dec 31.
9
Abdominal aortic calcification score among several vascular calcification scores of plain radiograph is the most reliable predictor of severe coronary artery calcification in dialysis patients.在普通 X 光片的几种血管钙化评分中,腹主动脉钙化评分是透析患者严重冠状动脉钙化的最可靠预测因子。
Ren Fail. 2017 Nov;39(1):729-735. doi: 10.1080/0886022X.2017.1398666.
10
Pre-existing arterial pathologic changes affecting arteriovenous fistula patency and cardiovascular mortality in hemodialysis patients.影响血液透析患者动静脉内瘘通畅性和心血管死亡率的既往动脉病理改变。
Korean J Intern Med. 2017 Sep;32(5):790-797. doi: 10.3904/kjim.2017.268. Epub 2017 Aug 22.